Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma

Virchows Archiv

Volumn 440, Issue 4, 2002, Pages 404-409

  Sakamoto, A ^a   Oda, Y ^a   Yamamoto, H ^a   Oshiro, Y ^b   Miyajima, K ^a   Itakura, E ^a   Tamiya, S ^a   Honda, Y ^c   Ishihara, A ^d   Iwamoto, Y ^a   Tsuneyoshi, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b MATSUYAMA RED CROSS HOSPITAL   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d Nobeoka Prefectural Hospital   (Japan)

Author keywords

Atypical fibroxanthoma; Benign fibrous histiocytoma; Calponin; H caldesmon; Superficial leiomyosarcoma

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; BIOLOGICAL MARKER; CALDESMON; CALPONIN;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; FIBROHISTIOCYTOMA; FIBROXANTHOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEIOMYOSARCOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MUSCLE DEVELOPMENT; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE; SPINDLE CELL CARCINOMA; SUN EXPOSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CALCIUM-BINDING PROTEINS; CALMODULIN-BINDING PROTEINS; CELL DIVISION; CELL NUCLEUS; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LEIOMYOSARCOMA; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036216633     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100521     Document Type: Article

References (28)

1. Atypical 'pseudosarcomatous' variant of cutaneous benign fibrous histiocytoma: Report of eight cases
2. Spindle-cell non-pleomorphic atypical fibroxanthoma: Analysis of a series and delineation of a distinctive variant
3. Atypical fibroxanthoma of the skin. A clinicopathological study of 57 cases
4. Ultraviolet-induced p53 mutations in atypical fibroxanthoma
5. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases
6. Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin
7. Smooth muscle specific expression of calponin
8. Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content
9. Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study
10. Atypical fibroxanthoma
11. Atypical fibroxanthoma of the skin with metastasis
12. Reduced expression of calponin h1 in leiomyosarcoma of the uterus
13. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue
14. Atypical fibroxanthoma. Multiple immunohistologic profiles
15. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans
16. Calponin and h-caldesmon in soft tissue tumors: Consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation
17. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining
18. Atypical fibroxanthoma. A study of 14 cases emphasizing the presence of Langerhans' histiocytes with implications for differential diagnosis by antibody panels
19. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma
20. A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation
21. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins
22. Purification and characterization of caldesmon77: A calmodulin-binding protein that interacts with actin filaments from bovine adrenal medulla
23. Isolation and characterization of a 34,000-dalton calmodulin- and F-actin-binding protein from chicken gizzard smooth muscle
24. Occurrence of anti-gizzard P34 K antibody cross-reactive components in bovine smooth muscles and non-smooth muscle tissues
25. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells
26. h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: Its specific expression in the smooth muscle cell tumor
27. Cutaneous sarcomas and sarcomatoid neoplasms of the skin